RSS
23 Feb 2021

RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.

Author: admintech | Filed under: Press Release

TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced its plans to expand the Company’s global Phase 2/3 study of opaganib[1] in patients with severe…

This entry was posted on Tuesday, February 23rd, 2021 at 7:12 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»